Net margin of 11.9% in 2026Q3 still trails the 14.3% recorded in 2025Q4, which implies the 630bp gross margin gain has not fully converted to the bottom line once the 420bp SG&A creep and the elevated $3.3M quarterly stock-based charge are recognised. Free cash flow margin of 27.5% in the same quarter sits far above the 8.8% troughs seen in 2025Q1 and 2026Q1, so part of that strength likely reflects working-capital timing rather than a new run rate. On a non-recurring-adjusted basis, gross margin appears to be the most reliable single indicator of CTS's true earning power, with operating margin the better test of whether overhead discipline is keeping pace.

ROE has oscillated in a tight 2.5-3.6% quarterly band and ROA between 1.7% and 2.5%, implying returns are stable rather than compounding; if these are quarterly readings as labelled, they annualise to roughly 13% ROE and 13-14% ROIC, respectable for a hybrid automotive-industrial supplier but still below the ~8.9% ROIC at peer Vicor on an annualised basis once scaled. Decomposition points squarely at margin rather than efficiency: gross margin rose 630bp while asset turnover improved only from 0.18 to 0.19, so nearly all return improvement is pricing and mix, not asset productivity. Because goodwill now represents roughly a quarter of total assets following the Ferroperm acquisition, investors should monitor whether ROIC on the tangible manufacturing base alone would tell a more flattering story than the blended figure.

The improvement appears to be split between receivables (DSO 58-60 historically versus 57 now) and payment terms (DPO rising from 47-51 to 54), while inventory days have not structurally improved at 65 versus a 58-65 range, suggesting CTS is extracting more from customer and supplier terms than from stock management. Asset turnover of 0.19 remains low in absolute terms, which is consistent with a fixed-cost ceramic firing and precision assembly model, and the 0.03 gain over ten quarters reads as discipline rather than a step-change in asset productivity. Given goodwill concentration, computing turnover on tangible assets excluding intangibles would likely show a materially different intensity picture and is worth doing before drawing peer comparisons.

Debt-to-EBITDA of 2.28x versus 4.67x a year earlier reflects deleveraging on both axes, with total debt down 36.6% year over year, so the improvement is not merely an EBITDA denominator effect and suggests the leverage trend is durable rather than cyclical. At 61.67x coverage, interest expense is effectively immaterial to earnings sensitivity, meaning CTS's results should be driven by operations rather than funding costs even in a sustained higher-rate backdrop. The more relevant analytical question is opportunity cost: a 0.15 D/E and persistent cash build may signal conservative deployment rather than balance-sheet necessity, echoing the absence of acquisition activity since Ferroperm.

The step-down from 27.04x trailing to 22.32x forward P/E implies consensus is modelling roughly 20% EPS growth, which looks demanding relative to 5.16% revenue growth and would require gross margins to hold near the 42% level rather than mean-reverting on precious metal costs. P/B of 3.20 sits above what a mid-teens return generator would normally justify, though approximately $207.4M of goodwill supports the book value denominator, which flatters the apparent asset backing. Versus peer Plexus at 36.79x P/E and 21.52x EV/EBITDA, CTS's 14.51x EV/EBITDA appears discounted, but that spread may reflect its classification as an automotive supplier rather than a mispricing investors can safely monetise.